Home | Medical-Newswire.Com:
(Medical-NewsWire.com, January 12, 2018 ) In this region, Europe IUCD Devices Market is projected to reach USD 757.5 million by 2024, from USD 561.7 million in 2016 growing at a CAGR of 3.9% in the forecast period 2017 to 2024
Based on geography, the Europe IUCD devices market is segmented into 11 geographical regions, such as,
Rest of Europe.
Explore More Information about report @ https://www.researchcosmos.com/reports/europe-intra-uterine-contraceptive-devices-market-analysis-industry-outlook-and-forecast-2017-to-2/1457411170
Europe IUCD devices market competition by top players including –
Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include
Ocon Medical Ltd.,
Pregna International Limited,
Medical Engineering Corporation SA ,
SMB Corporation and Meril Life Sciences Pvt. Ltd.,
Medu Scientific Ltd, China RH Contraceptives Co., Ltd,
Sanghai Jolly Medical Education Co., Ltd,
Bernstein Leibhard LLP,
Zheijang Daji Medical Instruments, Ltd.,
AME Line, Technico,
Injeflex Ind and Com Ltda,
Request free sample @ https://www.researchcosmos.com/request/1457411170
The Europe intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.
The Europe intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.
Inquire before buying @ https://www.researchcosmos.com/inquire/1457411170
On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.
Check for discount @https://www.researchcosmos.com/discount/1457411170
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Partner Relation Executive
Direct Line:+1 888 709 8757
+1 888 709 8757